E-Selectin/AAV Gene Therapy Promotes Myogenesis and Skeletal Muscle Recovery in a Mouse Hindlimb Ischemia Model
The response to ischemia in peripheral artery disease (PAD) depends on compensatory neovascularization and coordination of tissue regeneration. Identifying novel mechanisms regulating these processes is critical to the development of nonsurgical treatments for PAD. E-selectin is an adhesion molecule...
Saved in:
Main Authors: | Antoine J. Ribieras, Yulexi Y. Ortiz, Yan Li, Nga T. Le, Carlos T. Huerta, Francesca A. Voza, Hongwei Shao, Roberto I. Vazquez-Padron, Zhao-Jun Liu, Omaida C. Velazquez |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2023/6679390 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel GLP-Grade E-Selectin/AAV2 Gene Therapy Optimal Dosage for Vascular Regeneration
by: Francesca A. Voza, et al.
Published: (2024-01-01) -
Retinoic acid signalling inhibits myogenesis by blocking MYOD translation in pig skeletal muscle cells
by: Changying Wang, et al.
Published: (2024-12-01) -
Effects of FTY720 on Lung Injury Induced by Hindlimb Ischemia Reperfusion in Rats
by: Liangrong Wang, et al.
Published: (2017-01-01) -
Adipsin improves diabetic hindlimb ischemia through SERPINE1 dependent angiogenesis
by: Xiaohua Zhang, et al.
Published: (2024-12-01) -
Dyslipidemia impairs collateral artery formation after hindlimb ischemia: Adding insult to injury
by: Ali H. Hakim, MD, et al.
Published: (2024-01-01)